High Tide Inc. SEC Filings

High Tide Inc. reported the results of its August 11, 2026 annual general and special shareholder meeting. All five management nominees, including President and Chief Executive Officer Harkirat (Raj) Grover, were elected as directors, each receiving more than 97% of votes cast. Shareholders approved fixing the board at five directors, appointed Davidson & Company LLP as auditor for the ensuing year, and approved an Amended and Restated Shareholder Rights Plan. The company highlights its cannabis retail footprint of 229 Canadian Canna Cabana locations plus one international store, an estimated 12% share of the Canadian cannabis retail market, and a 14% share of the German medical cannabis market through subsidiary Remexian Pharma GmbH.

High Tide Inc. reported the outcomes of its annual general and special shareholders’ meeting held virtually on August 11, 2026. A total of 13,945,198 Common Shares, each carrying one vote, were present or represented by proxy, representing 15.87% of the issued and outstanding Common Shares entitled to vote.

Shareholders approved the matters presented with strong majorities. One resolution received 13,870,900 votes for and 74,298 withheld (99.47% support), and another received 13,654,995 votes for and 290,203 against (97.92% support). The director nominees, including Harkirat (Raj) Grover and four others, each received between 97.42% and 97.86% of votes cast in favor. Another matter obtained 12,700,154 votes for versus 1,244,706 against (91.07% support).

High Tide Inc. issued preliminary guidance for its third fiscal quarter ended July 31, 2026, calling for revenue of C$195.0–C$200.0 million, gross profit of C$51.0–C$53.5 million and Adjusted EBITDA of C$15.2–C$16.5 million. This corresponds to sequential growth of 9%–12%, 5%–11% and 9%–19%, and year-over-year growth of 30%–34%, 27%–33% and 43%–55%, respectively.

The company expects these to be record levels and notes that even the low end of each range is above the highest current analyst estimate. Growth is supported by Canadian bricks-and-mortar same-store sales returning to positive year-over-year in June and remaining positive in July, and by German subsidiary Remexian distributing over 10 tonnes of medical cannabis, up 33% sequentially and 60% year over year. Full Q3 results are expected on September 14, 2026, after markets close.

High Tide Inc. furnished an update as a foreign private issuer describing the opening of a new Canna Cabana retail cannabis store in Ottawa, Ontario. The store at 4828 Bank Street is expected to begin selling recreational cannabis products and accessories for adult use on July 24, 2026.

This opening brings Canna Cabana’s network to 229 stores across Canada, including 104 in Ontario, and serves a residential area of more than 25,000 people within five kilometres. High Tide highlights its vertically integrated cannabis operations, including Canna Cabana’s 12% Canadian retail market share and German subsidiary Remexian Pharma’s 14% share of the German medical cannabis market, while including customary cautionary language regarding forward-looking statements.

High Tide Inc. highlights direct engagement with retail shareholders as Founder & CEO Raj Grover hosts his fifth Reddit Ask Me Anything session on the company’s official subreddit, answering questions on strategy, operations and outlook.

The update situates the AMA within an active period that includes the release of second quarter fiscal 2026 results, an announced acquisition of Northern Helm, and approval of C$40 million in new senior credit facilities with BMO, alongside continued efforts to scale its majority-owned German medical cannabis business, Remexian Pharma GmbH.

High Tide describes itself as a leading community-grown, retail-forward cannabis enterprise. Its Canna Cabana chain is the largest cannabis retailer in Canada with 228 domestic and 1 international location, holding a growing 12% share of the Canadian market, while Remexian holds about 14% share of the German medical cannabis market and is licensed to import from 19 countries.

High Tide Inc. has implemented a shareholder rights plan and an amended and restated shareholder rights plan with Olympia Trust Company as rights agent. The plans are intended to ensure, to the extent possible, that all shareholders are treated fairly in any take-over bid and that the company can maintain its Cannabis Licenses and compliance with Cannabis Laws.

Under the agreements, one Right is issued for each Voting Share. After a defined Separation Time, each Right generally entitles the holder to purchase one common share at an Exercise Price equal to three times the Market Price, subject to detailed adjustment mechanisms and anti-dilution provisions. A person becomes an “Acquiring Person” upon Beneficial Ownership of 20% or more of Voting Shares (plus an additional 1% in certain cases), triggering potential adjustments, including Flip-in Events that can render Rights owned by an Acquiring Person null and void.

The plans include provisions for redemption of Rights at $0.00001 per Right, Board fiduciary duties in responding to take-over bids, regulatory approvals from the TSXV and Nasdaq where required, and periodic reconfirmation by Independent Shareholders at every third annual meeting, failing which the agreements and all Rights terminate.

High Tide Inc. is convening a virtual annual general and special meeting of shareholders on August 11, 2026 at 10:00 a.m. Calgary time to address routine governance and a key protective measure. Shareholders of record as of June 29, 2026 may vote online, by phone, email or mail, using notice-and-access to review materials electronically.

Items include receiving audited financial statements for the year ended October 31, 2025, reappointing Davidson & Company LLP as auditor, fixing the board at five directors, and electing the proposed slate. Shareholders are also asked to ratify an Amended and Restated Shareholder Rights Plan, which largely maintains existing terms but tightens the definition of an acquiring person to capture cannabis licence holders in Ontario and British Columbia whose ownership could put High Tide offside regional cannabis licensing rules. The rights plan preserves a 20% trigger, 105-day bid period and 50% discount flip-in mechanics, and must be reconfirmed by shareholders every three years.

The circular also details executive and director compensation, including a 20% fixed equity incentive Omnibus Plan, outstanding option and RSU awards, and change-of-control severance and vesting terms for senior management.

High Tide Inc. is introducing new shareholder rights plans to protect its cannabis licenses and manage potential takeover bids. The board approved a Temporary Shareholder Rights Plan and an Amended and Restated Shareholder Rights Plan, both entered into with Olympia Trust Company as Rights Agent.

The amended plan builds on a 2025 rights plan and expands the definition of an “Acquiring Person” to capture certain Ontario and British Columbia cannabis retail licence holders whose ownership could breach local licensing limits. The plans are not in response to any specific or anticipated takeover bid.

The Amended and Restated Shareholder Rights Plan has been accepted by the TSXV subject to shareholder ratification within six months and will run for three years if approved at the August 11, 2026 meeting. The temporary plan addresses new retail operator restrictions until shareholder ratification and will lapse once the amended plan is approved.

High Tide Inc. filed a Form 6-K highlighting a news release about its German subsidiary, Remexian Pharma GmbH, showcasing exclusive Canadian medical cannabis brand partnerships at Mary Jane Berlin 2026. The event ran June 11–14, 2026 in Berlin, one of Europe’s largest cannabis trade shows.

Remexian presented medical cannabis products from Tribal, Highly Dutch Organic, Weed Me, The Loud Plug, Joi Botanicals and Castle Rock Farms, connecting these Canadian brands with German pharmacies, healthcare professionals and patients. The company emphasizes Germany as one of the world’s fastest-growing medical cannabis markets.

The release also reiterates High Tide’s broader footprint: 228 Canna Cabana retail locations in Canada and 1 international store, a reported 12% share of the Canadian cannabis retail market, and Remexian’s stated 14% share of the German medical cannabis market with import licences from 19 countries.